000 01506 a2200421 4500
005 20250515233329.0
264 0 _c20110606
008 201106s 0 0 spa d
022 _a1130-6343
024 7 _a10.1016/j.farma.2010.01.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartín, M T
245 0 0 _a[Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy].
_h[electronic resource]
260 _bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_c
300 _a224-30 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Retroviral Agents
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aTime Factors
700 1 _aRovira, M
700 1 _aMassanes, M
700 1 _adel Cacho, E
700 1 _aCarcelero, E
700 1 _aTuset, M
700 1 _aCodina, C
700 1 _aMiro, J M
700 1 _aGatell, J M
700 1 _aRibas, J
773 0 _tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_gvol. 34
_gno. 5
_gp. 224-30
856 4 0 _uhttps://doi.org/10.1016/j.farma.2010.01.013
_zAvailable from publisher's website
999 _c20003696
_d20003696